Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipophilic toxin sequestration, or the "lipid sink" effect, is a process where lipophilic toxins are sequestered into a lipid phase, typically achieved by administering intravenous lipid emulsions (ILE). This reduces the free concentration of toxin available to interact with target tissues, mitigating toxicity. It is used in the treatment of acute poisoning by highly lipophilic drugs and toxins. Dietary nonabsorbable fats can also be used to bind mobilized toxins within the gut for fecal elimination.
Lipophilic toxins partition into the lipid phase, reducing the free concentration of toxin available to interact with target tissues.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipophilic Toxin Sequestration.